Business, Policy & Funding
Breaking news on Diagnostics business, policy & funding.
Xtrava Health COVID-19 Antigen Test May Be Impacted by Omicron Variants, FDA Says
The mutations impacting performance of the test include mutations of the nucleocapsid protein associated with the BA.1 and BA.2 variants.
CND Life Sciences, Beth Israel Ink Licensing Deal for Neurodegenerative Disease Test Technology
The agreement gives CND access to technologies key to CND's skin biopsy-based test for the hallmarks of the synucleinopathy family of neurodegenerative diseases.
Layoffs at Life Science, Dx Firms Continue as Thermo Fisher Scientific, Natera Shrink Payrolls
In 2023, Thermo Fisher has laid off nearly 400 California employees at sites associated with Mesa Biotech, acquired in 2021 for $450 million in cash.
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.
Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study
OSU investigators will offer the Guardant Shield assay to patients via mobile phlebotomists, studying adoption rates among approximately 300 individuals.